Fragments 2017 - 6th RSC-BMCS Fragment-based Drug Discovery meeting will focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes.

Domainex will be showcasing FragmentBuilder on our exhibition stand, and presenting a case study of Fragment screening against the lysine methyltransferase G9a, using MicroScale Thermophoresis.

Senior Assay Development Scientist, Katie Chapman, and Medicinal Chemist, Nick Martin will be at the event and look forward to discussing how Domainex can support your drug discovery programme.  If you would like to arrange a meeting with them at Fragments 2017, please get in touch.

We look forward to seeing you there.